Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

50.0%

% of PPH's 27 holdings also in XPH

32.4%

% of XPH's 40 holdings also in PPH

Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PPH
Weight
in XPH
Overlap
ELI LILLY & CO 6.1% 5.6% 5.6%
ZOETIS INC 4.6% 4.8% 4.6%
VIATRIS, INC. 4.2% 4.5% 4.2%
MERCK & CO. INC. 4.6% 4.2% 4.2%
JOHNSON & JOHNSON 4.7% 4.0% 4.0%

Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
TEVA PHARMACEUTICAL-SP ADR 5.8%
NOVO-NORDISK A/S-SPONS ADR 5.6%
ABBVIE INC 5.2%
SANOFI-AVENTIS-ADR 5.0%
NOVARTIS AG-ADR 4.9%
MCKESSON CORP 4.6%
GLAXOSMITHKLINE PLC-SPON ADR 4.6%
ASTRAZENECA PLC-SPONS ADR 4.3%
AMERISOURCEBERGEN CORP 4.3%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS 4.3%
PPH Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A -7.9%
AXSOME THERAPEUTICS, INC. -4.4%
ELANCO ANIMAL HEALTH, INC. -3.8%
ROYALTY PHARMA PLC CLASS A -3.7%
INTRA-CELLULAR THERAPIES INC -3.6%
VENTYX BIOSCIENCES, INC. -3.0%
CATALENT INC -2.7%
HARMONY BIOSCIENCES HOLDINGS, INC. -2.3%
CORCEPT THERAPEUTICS INC -2.2%
CYMABAY THERAPEUTICS, INC. -2.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY